Anastrozole is an oral medication that belongs to the class of aromatase inhibitors. It is prescribed primarily for the treatment of hormone receptor positive breast cancer in postmenopausal women. The drug works by blocking the enzyme aromatase, which converts androgens into estrogen in peripheral tissues. By reducing systemic estrogen levels, it slows the growth of estrogen dependent tumor cells. The decrease in estrogen removes the proliferative stimulus that fuels tumor progression. This mechanism provides a targeted therapeutic effect without directly interfering with other hormonal pathways.

Anastrozole is a medication classified as an aromatase inhibitor used in hormone-dependent breast cancer. It works by blocking the enzyme aromatase which converts androgens into estrogen in peripheral tissues. By reducing systemic estrogen levels it slows the growth of estrogen-responsive tumor cells. The pharmacodynamic effect of Anastrozole is a marked decrease in circulating estradiol concentrations with only modest changes in testosterone. Its pharmacokinetic profile shows high oral bioavailability and extensive binding to plasma proteins over several days. The drug is metabolized mainly by the liver cytochrome p450 enzymes and eliminated primarily through hepatic excretion. Because it does not directly antagonize the estrogen receptor it avoids some of the side effects associated with anti-estrogen therapies. Overall Anastrozole provides a targeted reduction of estrogen that underlies its clinical efficacy in post-menopausal breast cancer.

Many people experience mild headaches, which are usually temporary. Some may feel nausea or occasional dizziness after consumption. Fatigue can occur, especially during the initial adjustment period. Changes in appetite are reported by a minority of users. Mild skin reactions such as rash or itching can appear. Temporary digestive disturbances like gas or bloating are also possible. Most side effects tend to lessen as the body adapts over time.

Common side effects often include mild headaches and occasional dizziness. Some people experience temporary nausea or stomach discomfort after use. Fatigue or mild insomnia can occur in a minority of users. Skin reactions such as redness or itching are reported occasionally. In rare cases, individuals may notice changes in taste sensation. These effects are generally short lived and resolve without intervention. The frequency and intensity of symptoms can vary based on dosage and individual health factors. Most reported issues are not serious and do not require medical attention.